MangoRx said it has strong arguments against Eli Lilly’s claims. Image credit: Shutterstock / Cynthia A Jackson. MangoRx said ...

Disruption is a pressing problem in the pharmaceutical world; patient health depends on clinical trial organisers avoiding it ...

The IOF highlights the importance of collaborative efforts in treating osteoporosis, ensuring appropriate care globally.

Avacta Therapeutics has entered a strategic collaboration with Tempus AI to advance the development of drugs in oncology.

The oral semaglutide reduced the occurrence of major adverse cardiovascular events (MACE) by 14% in patients with type 2 ...

Digital transformation is a pressing concern among leading pharma firms. Credit: Gorodenkoff / Shutterstock. IoT, cloud ...

The European Union's CHMP has recommended the approval of AstraZeneca and Ionis Pharmaceuticals’ Wainzua to treat ATTRv-PN.

Editas is partnering its CRISPR platform with Genevant’s LNP technology to develop novel gene editing medicines in a deal worth $283m.

GSK has announced a £50m ($54.3m) investment in a partnership with the University of Cambridge to expedite R&D in ...

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis ...

As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.